Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis.
Clin Chest Med
; 43(4): 617-630, 2022 12.
Article
em En
| MEDLINE
| ID: mdl-36344070
ABSTRACT
As routine care in cystic fibrosis (CF) becomes increasingly personalized, new opportunities to further focus care on the individual have emerged. These opportunities are increasingly filled through research in tools aiding drug selection, drug monitoring and titration, disease-relevant biomarkers, and evaluation of therapeutic benefits. Herein, we will discuss such research tools presently being translated into the clinic to improve the personalization of care in CF.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrose Cística
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Clin Chest Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos